Connor, Clark & Lunn Investment Management Ltd. 10x Genomics, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 10, 2023	BUY	$24.4 - $41.3 $612,074 - $1.04 Million	25,085 New	25,085 $914,000

Others Institutions Holding TXG

# of Institutions

292

Shares Held

94.7M

Call Options Held

263K

Put Options Held

85.1K

Vanguard Group Inc Valley Forge, PA

11M
Shares

$170 Million
0.0% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

10.8M
Shares

$167 Million
2.31% of portfolio
Morgan Stanley New York, NY

6.48M
Shares

$101 Million
0.01% of portfolio
Black Rock Inc. New York, NY

6.39M
Shares

$99.3 Million
0.0% of portfolio
Nikko Asset Management Americas, Inc.

6.37M
Shares

$99 Million
1.67% of portfolio

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.48B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account